Skip to content

C86.40

Billable

Blastic NK-cell lymphoma not having achieved remission

HCC Category Mapping

V28HCC 19Lymphoma and Other Cancers
0.105
V24HCC 10Lymphoma and Other Cancers
0.675
ESRDHCC 10Lymphoma and Other Cancers
0.000
RxHCCHCC 21Hodgkin Lymphoma and Other Cancers
0.000

What This Code Means

A rare, aggressive lymphoma caused by abnormal NK-cells with blast-like features that has not achieved remission.

Coding Tips

  • Verify blastic morphology is confirmed in pathology report
  • Ensure active disease status is documented

Clinical Significance

Blastic NK-cell lymphoma (now more precisely classified as blastic plasmacytoid dendritic cell neoplasm) is an extremely rare, aggressive hematologic malignancy with immature blast-like morphology. It often presents with skin involvement followed by rapid dissemination to bone marrow, lymph nodes, and other organs. Non-remission status carries a very poor prognosis with median survival typically under 18 months.

Documentation Requirements

  • Pathology confirmation with immunohistochemistry demonstrating blastic NK-cell markers (CD56, CD4, CD123) is essential.
  • Documentation must include disease extent, sites of involvement (skin, marrow, nodes), treatment regimen, response assessment, and explicit statement that remission has not been achieved.

Commonly Confused Codes

Code Hierarchy

Open C86.40 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.